Wednesday, April 8, 2020
Patent Buyouts And Challenge Prizes
Professors Lisa Ouellette and Daniel Hemel have published a terrific article today (April 8, 2020) in the New York Times. Entitled "Pharmaceutical Profits and Public Health Are Not Incompatible: We need the capital and creativity of the private sector to take on the coronavirus", it proposes the use of government prizes or market-price buyouts of patent rights to spur and distribute successful treatments to combat SARS-CoV-2 and the Covid-19 it causes. If such a prize were to lead to a cure, all of society would be the winner.